Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy
Clinical trial NCT05583552 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05583552
- Sponsor
- GCP-Service International West GmbH
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-05
- Primary completion
- 2025-03-27
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.